These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3416483)

  • 41. [Pulmonary embolism and disseminated intravascular coagulation after being bitten by a Bothrops lanceolatus snake. Apropos of a case].
    Estrade G; Garnier D; Bernasconi F; Donatien Y
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1903-5. PubMed ID: 2514645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A sporadic case of protein C deficiency].
    Ishimaru F; Hayashi H; Ueki K; Fujita T; Tsurumi N; Tsuda T; Kimura I
    Rinsho Ketsueki; 1990 Nov; 31(11):1856-61. PubMed ID: 2287072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH.
    Cooper PC; Pavlova A; Moore GW; Hickey KP; Marlar RA
    J Thromb Haemost; 2020 Feb; 18(2):271-277. PubMed ID: 31999059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Isolation and properties of the protein C activator from Agkistrodon halys halys venom].
    Gornitskaia OV; Platonova TN
    Biomed Khim; 2003; 49(5):470-8. PubMed ID: 16119100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated plasma levels of hepatocyte growth factor in rats experimentally envenomated with Bothrops jararaca venom: Role of snake venom metalloproteases.
    Prezoto BC; Kato EE; Gonçalves LRC; Sampaio SC; Sano-Martins IS
    Toxicon; 2019 Apr; 162():9-14. PubMed ID: 30849454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical management of protein C deficiency.
    Pescatore SL
    Expert Opin Pharmacother; 2001 Mar; 2(3):431-9. PubMed ID: 11336597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
    Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF
    Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical features of twig snake (Thelotornis capensis) envenomation.
    Atkinson PM; Bradlow BA; White JA; Greig HB; Gaillard MC
    S Afr Med J; 1980 Dec; 58(25):1007-11. PubMed ID: 7444704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Snake venom proteins in hemostasis: new results].
    Stocker K; Meier J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):935-53. PubMed ID: 2483713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Marked discrepancy between coagulometric protein C activity assays with the pro-thrombotic protein C Asn2Ile substitution.
    Cooper PC; Siddiq S; Morse C; Nightingale J; Mumford AD
    Int J Lab Hematol; 2011 Oct; 33(5):451-6. PubMed ID: 21418542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enzyme immunoassay of human protein C by using monoclonal antibodies.
    Suzuki K; Moriguchi A; Nagayoshi A; Mutoh S; Katsuki S; Hashimoto S
    Thromb Res; 1985 Jun; 38(6):611-21. PubMed ID: 3895562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
    Ettingshausen CE; Veldmann A; Beeg T; Schneider W; Jäger G; Kreuz W
    Semin Thromb Hemost; 1999; 25(6):537-41. PubMed ID: 10632475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta 2-glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant.
    Brighton TA; Hogg PJ; Dai YP; Murray BH; Chong BH; Chesterman CN
    Br J Haematol; 1996 Apr; 93(1):185-94. PubMed ID: 8611459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hereditary protein C deficiency: a review of the genetics, clinical presentation, diagnosis and treatment.
    Marlar RA; Mastovich S
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):319-30. PubMed ID: 2103316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticoagulant response to Agkistrodon contortrix venom (ACV test): a new global test to screen for defects in the anticoagulant protein C pathway.
    Robert A; Eschwège V; Hameg H; Drouet L; Aillaud MF
    Thromb Haemost; 1996 Apr; 75(4):562-6. PubMed ID: 8743179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A plasma protein C activity assay suitable for a clinical laboratory. Its use to measure activity in hereditary and acquired deficiency states.
    Rapaport SI; Zivelin A; Donnelly K
    Am J Clin Pathol; 1987 Apr; 87(4):491-7. PubMed ID: 3826014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An international collaborative study on the performance of protein C antigen assays. Report of the ICTH subcommittee on protein C. International Committee on Thrombosis and Haemostasis.
    Bertina RM
    Thromb Haemost; 1987 Feb; 57(1):112-7. PubMed ID: 3590075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical usefulness of global assays of the anticoagulant pathway of protein C].
    Toulon P
    Ann Biol Clin (Paris); 2001; 59(5):545-50. PubMed ID: 11602384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antithrombotic effect of protein C activator from a snake venom].
    Strukova SM; Kogan AE; Tara AA; Aaviksaar AA
    Vopr Med Khim; 1989; 35(5):115-9. PubMed ID: 2617927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fast functional protein C assay using Protac, a novel protein C activator.
    Martinoli JL; Stocker K
    Thromb Res; 1986 Aug; 43(3):253-64. PubMed ID: 3526629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.